ACT18018
Brief description of study
This study will look at the efficacy, safety, and tolerability of itepekimab, in people with non-cystic fibrosis bronchiectasis. Patients will be asked to complete a CT, lab tests, safety labs, lung function tests, PEs, ECGs, and questionnaires.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: - 99 Years
-
Gender: All
TBD
Find a site
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
